A.S.R.
For the specified overview of A.S.R. you need to log in to A.S.R.
Log in with your DigiD on the website and view "declaratieoverzicht". Click "farmacie" and then "eigen…
Update Reimbursement Scheme Adempas®
As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric patients aged less than…
PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS
General information
The pharmacist has dispensed Adempas® 0.5 or 1mg to the patient. The health insurer will not…
General information
The pharmacist has dispensed PLENADREN® 5 or 20mg to you. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of this medicine has…
General information
The pharmacist has dispensed Signifor® 20 mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The producer of this medicine has…
General information
The pharmacist has dispensed ELVANSE® 20, 30, 40, 50, 60 or 70mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The…
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine
Check Medicine Expenses
General information
The pharmacist has dispensed Intuniv® 1,…
TBR Nederland provides the following Reimbursement Schemes for the medicines below. No reimbursement is determined yet for these medicines, as a result of which you have to pay a…
General information
You have given Jardiance® 10 mg to a patient or you have obtained this medicine from the pharmacy. The health care insurer does not yet reimburse Jardiance® for the treatment of…
General information
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction (HFrEF, HFmrEF and HFpEF) is regularly reimbursed…
